Durham

The trials here

What the 7 trials at this site are about, from their registry records.

Conditions

• Colorectal cancer2 trials
• HIV2 trials
• Endometrial cancer1 trial
• Fatty liver disease (MASLD/MASH)1 trial
• Pancreatic cancer1 trial
• Primary biliary cholangitis1 trial

Phase

• Phase 34 trials
• Phase 22 trials
• Phase 1/21 trial

Status

• Active, not recruiting3 trials
• Recruiting3 trials
• Completed1 trial

Lead sponsor

• GlaxoSmithKline4 trials
• ViiV Healthcare2 trials
• Tesaro, Inc.1 trial

Running trials

• Recruiting

  A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)

  NCT07202546· Phase 2· ViiV Healthcare· Source

  Contact: Mehri McKellar (principal investigator)

• Recruiting

  A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed (EMBOLD PanGI-201)

  NCT06885034· Phase 1/2· GlaxoSmithKline· Source

  Contact: Nicholas Devito (principal investigator)

• Recruiting

  Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

  NCT05855200· Phase 3· GlaxoSmithKline· Source

  Contact: John Strickler (principal investigator)

• Active, not recruiting

  Linerixibat Long-term Safety, and Tolerability Study

  NCT04167358· Phase 3· GlaxoSmithKline· Source

• Active, not recruiting

  A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer

  NCT03981796· Phase 3· Tesaro, Inc.· Source

• Active, not recruiting

  Attachment Inhibitor Comparison in Heavily Treatment Experienced Patients

  NCT02362503· Phase 3· ViiV Healthcare· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Colorectal cancer2 recruiting
• HIV1 recruiting
• Pancreatic cancer1 recruiting

Closed trials

• Completed

  Phase 2b Study of GSK4532990 in Adults With NASH

  NCT05583344· Phase 2· GlaxoSmithKline· Source